Clinical Outcomes of Pediatric Cancer Patients with COVID-19: A Cross-Sectional Study
- PMID: 39703466
- PMCID: PMC11652701
- DOI: 10.18502/ijhoscr.v18i4.16756
Clinical Outcomes of Pediatric Cancer Patients with COVID-19: A Cross-Sectional Study
Abstract
Background: Considering the widespread COVID-19 pandemic and its impact, especially on children, particularly those with cancer, in terms of transmission risk, mortality, and the occurrence of the disease based on various studies in different countries, we decided to conduct this study to improve the care of children with cancer regarding COVID-19. Materials and Methods: A descriptive cross-sectional study with a confirmed diagnosis of COVID-19 consisted of obtaining 20 mL of blood samples from the participants in a random manner. Diagnostic examinations, including CT scans, chest X-rays, and a range of hematologic and blood tests, such as complete blood count, ESR, CRP, and D-Dimer, were performed on all patients. Results: This study contains 26 males and 12 females. The mean age of the patients was 3.81 ± 6.35 years. The majority of cancer patients with COVID-19 were diagnosed with Acute Lymphoblastic Leukemia (ALL) (47.7%). The most common symptoms of COVID-19 in the patients were fever (73.7%), cough (39.5%), and nausea/vomiting (21.1%). 40.4% of the patients had pathological findings suggestive of COVID-19 on their chest CT scans. 60.52% of the patients had an elevated Erythrocyte Sedimentation Rate (ESR), and 73.68% had an elevated C-reactive protein (CRP) level. Conclusion: Despite the outcomes of COVID-19 in most children with cancer in this study, children with cancer still experience risks from COVID-19, and it is unclear how delays and interruptions in cancer treatment and direct damage from the virus may impact long-term outcomes in these patients.
Keywords: Cancer; Covid-19; Pediatric oncology.
Copyright © 2024 Tehran University of Medical Sciences.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Zarebavani M, Baghaei Naeini F, Farahvash A, et al. Resveratrol attenuates chronic social isolation stress‐induced affective disorders: Involvement of NF‐κB/NLRP3 axis. J Biochem Mol Toxicol. 2023;37(5):e23311. - PubMed
-
- Naeini FB, Hassanpour S, Asghari A. Resveratrol exerts anxiolytic-like effects through anti-inflammatory and antioxidant activities in rats exposed to chronic social isolation. Behav Brain Res. 2023;438:114201. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous